术前深度单采自体红细胞和/或血小板储血技术应用中国专家共识OACSTPCD

Preoperative Advanced Autologous Apheresis(AAA)is a new type of preoperative autologous blood donation.In recent years,this technology has been introduced in many hospitals across the country.However,there has yet to be a consensus or technical standard for its implementation process and quality control.To address this,the Chinese Blood Transfusion Association Clinical Transfusion Management Committee organized experts from related fields nationwide to extensively and deeply discuss the technical principles,entry requirements,indications,contraindications,operational key points,adverse reaction prevention and treatment,and blood quality evaluation and disposition of preoperative Advanced Autologous Apheresis,and jointly formulated this consensus.The aim is to better manage autologous blood for patients and to provide a basis for medical staff to implement preoperative Advanced Autologous Apheresis more safely and standardized.